These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34305491)

  • 1. Forecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US, Asia, Europe, Africa, South America, and the World.
    Cihan P
    Appl Soft Comput; 2021 Nov; 111():107708. PubMed ID: 34305491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will vaccine-derived protective immunity curtail COVID-19 variants in the US?
    Mancuso M; Eikenberry SE; Gumel AB
    Infect Dis Model; 2021; 6():1110-1134. PubMed ID: 34518808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achieving herd immunity in South America.
    Lucero-Prisno DE; Shomuyiwa DO; Vicente CR; Méndez MJG; Qaderi S; Lopez JC; Mogessie YG; Alacapa J; Chamlagai L; Ndayizeye R; Kinay P
    Glob Health Res Policy; 2023 Feb; 8(1):2. PubMed ID: 36726143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Africa achieve herd immunity?
    Lucero-Prisno DE; Ogunkola IO; Esu EB; Adebisi YA; Lin X; Li H
    Glob Health Res Policy; 2021 Dec; 6(1):46. PubMed ID: 34852844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continent-Wide Analysis of COVID 19: Total Cases, Deaths, Tests, Socio-Economic, and Morbidity Factors Associated to the Mortality Rate, and Forecasting Analysis in 2020-2021.
    Zahid MN; Perna S
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34069764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.
    Kouamou V; Matarise R; Santos ED; Elose N; Manasa J
    Pan Afr Med J; 2021; 39():255. PubMed ID: 34707756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
    MacIntyre CR; Costantino V; Trent M
    Vaccine; 2022 Apr; 40(17):2506-2513. PubMed ID: 33958223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the development trend and severity of the COVID-19 panidemic in the global world].
    Huang B; Wang HY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):536-542. PubMed ID: 34145857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
    She J; Hou D; Chen C; Bi J; Song Y
    Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of COVID-19 vaccination around South Asia.
    Hayat M; Uzair M; Ali Syed R; Arshad M; Bashir S
    Hum Vaccin Immunother; 2022 Dec; 18(1):2016010. PubMed ID: 35061956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of age structure and vaccine prioritization on COVID-19 in West Africa.
    Taboe HB; Asare-Baah M; Yesmin A; Ngonghala CN
    Infect Dis Model; 2022 Dec; 7(4):709-727. PubMed ID: 36097593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Vaccination Rates on the Infection of COVID-19 under the Vaccination Rate below the Herd Immunity Threshold.
    Chen YT
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herd Immunity to Fight Against COVID-19: A Narrative Review.
    Suryawanshi YN; Biswas DA
    Cureus; 2023 Jan; 15(1):e33575. PubMed ID: 36779140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information about herd immunity through vaccination and empathy promote COVID-19 vaccination intentions.
    Pfattheicher S; Petersen MB; Böhm R
    Health Psychol; 2022 Feb; 41(2):85-93. PubMed ID: 34570535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
    Causey K; Fullman N; Sorensen RJD; Galles NC; Zheng P; Aravkin A; Danovaro-Holliday MC; Martinez-Piedra R; Sodha SV; Velandia-González MP; Gacic-Dobo M; Castro E; He J; Schipp M; Deen A; Hay SI; Lim SS; Mosser JF
    Lancet; 2021 Aug; 398(10299):522-534. PubMed ID: 34273292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity.
    Pacheco-García U; Serafín-López J
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of COVID-19 Vaccine Policies in Italy, India, and South Africa.
    Yang M; Shi L; Chen H; Wang X; Jiao J; Liu M; Yang J; Sun G
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.